Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis

Open Access

Peer-reviewed

Research Article

Shi-jie Zhao,

Affiliation Department of Geriatric Cardiology, First Affiliated Hospital, China Medical University, Shenyang, China
⨯
Zhao-shuang Zhong,

Affiliation Department of Respiratory, Central Hospital, Shenyang Medical College, Shenyang, China
⨯
Guo-xian Qi,

Affiliation Department of Geriatric Cardiology, First Affiliated Hospital, China Medical University, Shenyang, China
⨯
Li-ye Shi,

Affiliation Department of Geriatric Cardiology, First Affiliated Hospital, China Medical University, Shenyang, China
⨯
Ling Chen,

Affiliation Department of Geriatric Cardiology, First Affiliated Hospital, China Medical University, Shenyang, China
⨯
Wen Tian

* E-mail: dr_wentian@163.com

Affiliation Department of Geriatric Cardiology, First Affiliated Hospital, China Medical University, Shenyang, China
⨯

Reader Comments (0)

Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Stent implantation
Is the Subject Area "Stent implantation" applicable to this article?

Thanks for your feedback.
Database searching
Is the Subject Area "Database searching" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Coronary stenting
Is the Subject Area "Coronary stenting" applicable to this article?

Thanks for your feedback.
Publication ethics
Is the Subject Area "Publication ethics" applicable to this article?

Thanks for your feedback.